TG Therapeutics | TGTX - Trade Creditors


TG Therapeutics reported $148.84M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Curis USD 5.61M 1.52M Dec/2025
Gilead Sciences USD 645M 70M Mar/2026
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
J&J USD 10.46B 1.53B Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Novavax USD 16.1M 8.48M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 148.84M 41.34M Mar/2026
Verastem USD 12.45M 2.56M Dec/2025
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026